Detail page

Knowledge Web

Person

Ilona Jandová

Ärztin

Name	Ilona Jandová
Place	Třebíč (Geburtsort) Deutschland
Profession	Ärztin (characteristic profession)
Variant	Ilona Mastná (früherer Name)
Related	Klinik für Rheumatologie und Klinische Immunologie (Freiburg im Breisgau)
Further information	Dissertation 2022, Albert-Ludwigs-Universität Freiburg im Breisgau, Medizinische Fakultät
Record type	Person
GND-Identifier	1221646702
Record ID	1221646702
Involved in show all Chronic low-grade inflammation in patients with systemic sclerosis is associated with increased risk for arteriosclerotic cardiovascular disease Impact of systemic Sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival : : a large cohort study of the German network for systemic Sclerosis Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases Inflammatory arthritis in systemic sclerosis is associated with elevated C-reactive protein and requires musculoskeletal ultrasound for reliable detection Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms Autologous hematopoietic stem cell transplantation improves long-term survival - data from a national registry Rituximab als remissionserhaltende Therapie bei ANCA-assoziierter Vaskulitis Case report : Lymphohistiocytic Myocarditis with severe cardiogenic shock requiring mechanical cardiocirculatory support in multisystem inflammatory syndrome following SARS-CoV-2 infection Case report: effective and safe treatment with certolizumab pegol in pregnant patients with cogan’s syndrome: a report of three pregnancies in two patients Case report: lymphohistiocytic myocarditis with severe cardiogenic shock requiring mechanical cardiocirculatory support in multisystem inflammatory syndrome following SARS-CoV-2 infection Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Ilona Jandová

Chronic low-grade inflammation in patients with systemic sclerosis is associated with increased risk for arteriosclerotic cardiovascular disease

Impact of systemic Sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival : : a large cohort study of the German network for systemic Sclerosis

Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases

Inflammatory arthritis in systemic sclerosis is associated with elevated C-reactive protein and requires musculoskeletal ultrasound for reliable detection

Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms

Autologous hematopoietic stem cell transplantation improves long-term survival - data from a national registry

Rituximab als remissionserhaltende Therapie bei ANCA-assoziierter Vaskulitis

Case report : Lymphohistiocytic Myocarditis with severe cardiogenic shock requiring mechanical cardiocirculatory support in multisystem inflammatory syndrome following SARS-CoV-2 infection

Case report: effective and safe treatment with certolizumab pegol in pregnant patients with cogan’s syndrome: a report of three pregnancies in two patients

Case report: lymphohistiocytic myocarditis with severe cardiogenic shock requiring mechanical cardiocirculatory support in multisystem inflammatory syndrome following SARS-CoV-2 infection

Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets